ISB News

ISB Artwork Featured On Cover of Nature Biotechnology

isbscience.org/news/2017/08/14/isb-artwork-nature-biotechnology-cover/
 Posted on August 14, 2017

The Institute for Systems Biology and Arivale “Pioneer 100 Study” is featured on the cover of August’s Nature Biotechnology. The artwork was created by ISB’s Associate Director of Communications Allison Kudla in collaboration with contributing author John C. Earls, software engineer in the Hood-Price Lab.

About the cover: A subset of statistically significant correlations are extruded in three-dimensional space. Price et al. describe the integration of whole genome sequences; clinical tests, metabolomes, proteomes, and microbiomes at three time points; and regular quantified self-measurements for 108 individuals over 9 months. They obtain thousands of cross-sectional interomic correlations, each represented by a line in the circular figure, to better understand health and disease. Image credit: Allison Kudla, John C. Earls (Institute for Systems Biology)

 Category: 100K Wellness Project, Publications, Scientific Wellness

 Tags:, , , , , , , , ,

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

     Posted on July 16, 2024

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

     Posted on July 10, 2024

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

     Posted on July 9, 2024

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.

Sitemap

Institute for Systems Biology is a nonprofit scientific research organization located in Seattle © 2024 · All Rights Reserved · Institute for Systems Biology

RSS Feed · Log in